Provided by Tiger Trade Technology Pte. Ltd.

Serina Therapeutics, Inc.

1.76
-0.0499-2.76%
Volume:13.92K
Turnover:24.77K
Market Cap:26.40M
PE:-0.88
High:1.79
Open:1.78
Low:1.76
Close:1.81
52wk High:7.92
52wk Low:1.22
Shares:15.00M
Float Shares:5.31M
Volume Ratio:0.39
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0109
EPS(LYR):-1.9100
ROE:-221.93%
ROA:-89.79%
PB:2.08
PE(LYR):-0.92

Loading ...

Company Profile

Company Name:
Serina Therapeutics, Inc.
Exchange:
AMEX
Establishment Date:
2006
Employees:
16
Office Location:
601 Genome Way,Suite 2001,Huntsville,Alabama,United States
Zip Code:
35806
Fax:
- -
Introduction:
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.

Directors

Name
Position
Balkrishan Gill
Director and Executive Chairman of the Board
Steve Ledger
Chief Executive Officer and Director
Gregory H. Bailey
Director
Jay Venkatesan
Director
Karen Wilson
Director
Richard Marshall
Director
Stephen Brannan
Director

Shareholders

Name
Position
Steve Ledger
Chief Executive Officer and Director
Gregory S. Curhan
Chief Financial Officer
Balkrishan Gill
Director and Executive Chairman of the Board
Randall Moreadith
Chief Development Officer
Srini Tenjarla
SVP CMC & Formulation